acrylic acid has been researched along with arsenic trioxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, W; Guo, M; Li, F; Liu, Y; Wei, Y; Xiao, X; Zhang, R; Zhang, Y; Zheng, G; Zheng, H | 1 |
| Chen, XJ; Fan, XD; Li, FZ; Piao, JG; Wang, BH; Wei, YH; Zhang, BB; Zheng, HS; Zheng, HY; Zhu, JJ | 1 |
2 other study(ies) available for acrylic acid and arsenic trioxide
| Article | Year |
|---|---|
pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Topics: Absorption, Physicochemical; Acrylic Resins; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Delivery Systems; Drug Synergism; Female; Humans; Hydrogen-Ion Concentration; Male; Nanocapsules; Nanopores; Neoplasms, Experimental; Oxides; Rats; Rats, Sprague-Dawley; Silicon Dioxide; Treatment Outcome | 2016 |
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Topics: Acrylic Resins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Breast Neoplasms; Cell Proliferation; Cetrimonium; Drug Carriers; Drug Liberation; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice, Inbred ICR; Nanoparticles; Oligopeptides; Paclitaxel; Porosity; Silicon Dioxide; Xenograft Model Antitumor Assays | 2021 |